Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19
- PMID: 32852826
- PMCID: PMC7436583
- DOI: 10.1111/apt.15946
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19
Erratum in
-
Corrigendum.Aliment Pharmacol Ther. 2020 Nov;52(9):1535. doi: 10.1111/apt.16103. Aliment Pharmacol Ther. 2020. PMID: 33263383 Free PMC article. No abstract available.
Abstract
LINKED CONTENT
This article is linked to Tian et al and Tian and Rong papers. To view these articles, visit
Comment in
-
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with coronavirus disease 2019-authors' reply.Aliment Pharmacol Ther. 2020 Sep;52(5):904-905. doi: 10.1111/apt.15986. Aliment Pharmacol Ther. 2020. PMID: 32852827 Free PMC article.
Comment on
-
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission.Aliment Pharmacol Ther. 2020 May;51(9):843-851. doi: 10.1111/apt.15731. Epub 2020 Mar 31. Aliment Pharmacol Ther. 2020. PMID: 32222988 Free PMC article. Review.
References
-
- Svedlund J, Sjödin I, Dotevall G. GSRS a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129–134. - PubMed